Extending those studies to a larger cohort of 68 samples (the TX cohort) led to the identification of several subgroups of ACC tumors with unique gene expression signatures, including one subgroup with poor survival and a ‘No Myb’ group that expressed neither MYB nor MYBL1 [6]. The gene discussed is MYBL1; the disease is adrenal cortex carcinoma.